Buitrago, Liseth Yamile Wilches; Viacava, Paula Ramos; Cunha, Fernando de Queiroz 
; Alves Filho, José Carlos Farias ; Fukada, Sandra Yasuyo
Source: Inflammation Research. Unidades: FMRP, FCFRP
Subjects: REMODELAÇÃO ÓSSEA, OSTEOCLASTO, FRUTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUITRAGO, Liseth Yamile Wilches et al. Fructose 1,6-bisphosphate inhibits osteoclastogenesis by attenuating RANKL-induced NF-κB/NFATc-1. Inflammation Research, v. 68, n. 5, p. 415-421, 2019Tradução . . Disponível em: https://doi.org/10.1007/s00011-019-01228-w. Acesso em: 03 out. 2024.APA
Buitrago, L. Y. W., Viacava, P. R., Cunha, F. de Q., Alves Filho, J. C. F., & Fukada, S. Y. (2019). Fructose 1,6-bisphosphate inhibits osteoclastogenesis by attenuating RANKL-induced NF-κB/NFATc-1. Inflammation Research, 68( 5), 415-421. doi:10.1007/s00011-019-01228-wNLM
Buitrago LYW, Viacava PR, Cunha F de Q, Alves Filho JCF, Fukada SY. Fructose 1,6-bisphosphate inhibits osteoclastogenesis by attenuating RANKL-induced NF-κB/NFATc-1 [Internet]. Inflammation Research. 2019 ; 68( 5): 415-421.[citado 2024 out. 03 ] Available from: https://doi.org/10.1007/s00011-019-01228-wVancouver
Buitrago LYW, Viacava PR, Cunha F de Q, Alves Filho JCF, Fukada SY. Fructose 1,6-bisphosphate inhibits osteoclastogenesis by attenuating RANKL-induced NF-κB/NFATc-1 [Internet]. Inflammation Research. 2019 ; 68( 5): 415-421.[citado 2024 out. 03 ] Available from: https://doi.org/10.1007/s00011-019-01228-w
